Showing results (641-650 of 689) with videos related to
Sort By:
Pageof 69
Circulation|December 7, 2007
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trialStephen D Wiviott, Dietmar Trenk, Andrew L Frelinger, et al.Circulation|November 1, 2006
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategyDuane S Pinto, Ajay J Kirtane, Brahmajee K Nallamothu, et al.Journal of the American College of Cardiology|November 7, 1999
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial InfarctionC M Gibson, S Murphy, I B Menown, et al.The American Journal of Cardiology|November 7, 2009
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY)Jason P Linefsky, Min Lin, Karen S Pieper, et al.Circulation|June 3, 1999
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 InvestigatorsE M Antman, R P Giugliano, C M Gibson, et al.International Journal of Cardiology|November 18, 2008
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey, Simon T Tonev, Sarah A Spinler, et al.JAMA|July 9, 2004
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overviewJohn L Petersen, Kenneth W Mahaffey, Vic Hasselblad, et al.International Journal of Cardiology|May 2, 2009
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGYSarah A Spinler, Kenneth W Mahaffey, Dianne Gallup, et al.European Heart Journal|November 10, 2000
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 InvestigatorsE M Antman, C M Gibson, J A de Lemos, et al.European Heart Journal|September 22, 2018
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trialsDavid D Berg, Stephen D Wiviott, Eugene Braunwald, et al.Pageof 69